Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
|---|---|---|---|---|---|
| C1837315 | COLORECTAL CANCER, SUSCEPTIBILITY TO, 1 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0017601 | Glaucoma | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0022658 | Kidney Diseases | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0152136 | Low Tension Glaucoma | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0027051 | Myocardial Infarction | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0009402 | Colorectal Carcinoma | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0027651 | Neoplasms | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0020456 | Hyperglycemia | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0028738 | Nystagmus | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C1319315 | Adenocarcinoma of large intestine | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C3554460 | COLORECTAL CANCER, SUSCEPTIBILITY TO, 12 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0346629 | Malignant neoplasm of large intestine | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0339573 | Glaucoma, Primary Open Angle | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0018790 | Cardiac Arrest | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0015695 | Fatty Liver | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0600139 | Prostate carcinoma | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C1269683 | Major Depressive Disorder | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C1306459 | Primary malignant neoplasm | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0006826 | Malignant Neoplasms | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0752124 | Spinocerebellar Ataxia Type 6 (disorder) | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0752125 | Spinocerebellar Ataxia Type 7 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C2711227 | Steatohepatitis | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0752120 | Spinocerebellar Ataxia Type 1 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
| C0028754 | Obesity | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
